Permanently Discontinued

APO AMPI LIQ 250MG/5ML

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is APO AMPI LIQ 250MG/5ML discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that APO AMPI LIQ 250MG/5ML has been permanently discontinued (last updated October 5, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is APO AMPI LIQ 250MG/5ML not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusPermanently Discontinued

Same-ingredient products on file4 products · 0 same form & route

Affected strength250MG

Report last updated2017-10-05

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

AMPICILLIN SODIUM FOR INJECTION BP

AURO PHARMA INC

250MG · DIN 02462303

Same strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

TEVA-AMPICILLIN

TEVA CANADA LIMITED

500MG · DIN 00020885

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

AMPICILLIN SODIUM FOR INJECTION, USP

TEVA CANADA LIMITED

500MG · DIN 00872652

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

AMPICILLIN FOR INJECTION, USP

FRESENIUS KABI CANADA LTD

500MG · DIN 02227010

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

00603287

Strength

250MG

Dosage Form

LIQUID

Route

ORAL

Active Ingredient

AMPICILLIN

See all AMPICILLIN products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2017-10-05

Active Shortage

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244